SEC Comment Letter 0000000000-26-004448 to Alpha Tau Medical Ltd. (DRTS)
Alpha Tau Medical Ltd.
Date: April 30, 2026 · CIK: 0001871321 · Accession: 0000000000-26-004448
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-295359
Letter
April 30, 2026 Uzi Sofer Chief Executive Officer Alpha Tau Medical Ltd. Kiryat HaMada St. 5 Jerusalem, Israel 9777605 Re: Alpha Tau Medical Ltd. Registration Statement on Form F-3 Filed April 28, 2026 File No. 333-295359 Dear Uzi Sofer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Nathan Ajiashvili, Esq.
Show Raw Text
April 30, 2026 Uzi Sofer Chief Executive Officer Alpha Tau Medical Ltd. Kiryat HaMada St. 5 Jerusalem, Israel 9777605 Re: Alpha Tau Medical Ltd. Registration Statement on Form F-3 Filed April 28, 2026 File No. 333-295359 Dear Uzi Sofer: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Nathan Ajiashvili, Esq.